glycyrrhizic acid has been researched along with Cirrhoses, Experimental Liver in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chuang, CL; Hou, MC; Hsu, SJ; Huang, HC; Huang, YH; Lee, FY; Pun, CK; Yen, CH | 1 |
Cai, DY; Deng, B; Liu, XT; Song, YJ; Wang, YQ; Xu, XY; Yang, SJ; Zhang, T; Zhao, X | 1 |
Feng, ZQ; Guo, XL; Jin, J; Liang, B; Ma, YC | 1 |
Chen, G; Chen, J; Liu, P; Mu, Y; Ren, S; Sun, M; Tong, X; Wang, X; Zhang, H; Zhou, Y | 1 |
Cai, Y; Shen, XZ; Wang, JY | 1 |
Chen, HM; Han, DW; Jiang, CF; Liu, JH; Ma, XH; Su, XS; Wang, LH; Zhao, MQ; Zhao, YC | 1 |
Kim, J; Ko, G; Park, EJ; Sohn, DH | 1 |
Abakumova, OIu; Fedorova, LM; Gavril'chak, AV; Iakusheva, IV; Kariakin, AV; Podobed, OV; Shekhter, AB; Tsvetkova, TA | 1 |
Guo, JS; Li, H; Liu, SL; Wang, JY; Zern, MA | 1 |
Guo, J; Liu, S; Wang, J | 1 |
Sata, M; Ueno, T | 1 |
1 review(s) available for glycyrrhizic acid and Cirrhoses, Experimental Liver
Article | Year |
---|---|
[Forefront of therapy for hepatic fibrosis].
Topics: Animals; Drugs, Chinese Herbal; Genetic Therapy; Glycyrrhizic Acid; Humans; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Cirrhosis, Experimental; Mice; Rats | 2002 |
10 other study(ies) available for glycyrrhizic acid and Cirrhoses, Experimental Liver
Article | Year |
---|---|
Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
Topics: Animals; Anti-Inflammatory Agents; Collateral Circulation; Disease Models, Animal; Glycyrrhizic Acid; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Signal Transduction; Splanchnic Circulation; Vascular Endothelial Growth Factor Receptor-2 | 2021 |
Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
Topics: Animals; Antihypertensive Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Collagen; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Macrophages; Male; Nitric Oxide Synthase Type II; Perfusion; Peroxynitrous Acid; Portal Pressure; Rats; Rats, Wistar; Time Factors | 2013 |
Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Topics: Actins; Animals; Apoptosis; bcl-2-Associated X Protein; Carbon Tetrachloride; Caspase 3; Chemical and Drug Induced Liver Injury; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Cytoprotection; Glycyrrhizic Acid; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Protective Agents; Rats, Sprague-Dawley; RNA, Messenger | 2015 |
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Topics: Actins; Animals; Astragalus Plant; Cell Line; Cell Survival; Collagen Type I; Common Bile Duct; Dimethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation; Glycyrrhizic Acid; Hepatic Stellate Cells; Hydroxyproline; Ligation; Liver; Liver Cirrhosis, Experimental; Male; Mice; Phosphorylation; Phytotherapy; Plants, Medicinal; Protective Agents; Rats, Wistar; RNA, Messenger; Saponins; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2016 |
[Effects of glycyrrhizin on genes expression during the process of liver fibrosis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Gene Expression Regulation; Glycyrrhizic Acid; Liver Cirrhosis, Experimental; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Ubiquitin-Protein Ligases | 2003 |
Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Animals; Antiviral Agents; Chronic Disease; Fatty Liver; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Humans; Liver Cirrhosis, Experimental; Male; Middle Aged; Rats; Rats, Inbred Strains | 1984 |
Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction.
Topics: Animals; Basidiomycota; Body Weight; Cholestasis; Common Bile Duct Diseases; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Organ Size; Pentoxifylline; Polyporaceae; Polysaccharides; Rats; Rats, Sprague-Dawley | 1997 |
[A study of hepatoprotective effect of the preparation phospholiv containing phosphatidylcholine from sunflower seeds and glycyrrhizic acid in the model of liver cirrhosis in rats].
Topics: Animals; Carbon Tetrachloride Poisoning; DNA; Glycyrrhizic Acid; Helianthus; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Phosphatidylcholines; Plant Oils; Protein Biosynthesis; Rats; Rats, Wistar; RNA, Messenger; Seeds; Sunflower Oil | 1997 |
Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Ethanol; Glycyrrhizic Acid; Liver Cirrhosis, Experimental; Male; NF-kappa B; Rats; Rats, Sprague-Dawley | 1998 |
[Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCl4 plus ethanol induced liver cirrhosis in rats].
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Ethanol; Glycyrrhizic Acid; Liver Cirrhosis, Experimental; Male; NF-kappa B; Rats; Rats, Sprague-Dawley | 1999 |